| |
| |
|
| Insider
Information: |
Drachman Jonathan G |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
2,750,659 |
|
|
Indirect Shares
|
25,000 |
|
|
| Direct
Value |
$54,844,969 |
|
|
|
Indirect Value
|
$92,000 |
|
|
| Total
Shares |
2,775,659 |
|
|
| Total
Value |
$54,936,969 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -80.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
CMO & EVP, R & D |
2018-03-20 |
201,973 |
|
0 |
Premium* |
|
|
Neurogene |
NGNE |
President and CEO, Dir... |
2021-08-24 |
2,348,686 |
2021-08-25 |
25,000 |
Premium* |
|
|
Calithera Biosciences, Inc. |
CALA |
Director |
2021-11-10 |
200,000 |
2021-11-10 |
0 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
CMO & EVP, R & DOfficer |
• – – |
2013-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,012 |
|
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2013-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,100 |
51,112 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2014-01-16 |
4 |
AS |
$45.75 |
$54,946 |
D/D |
(1,201) |
49,911 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2014-02-20 |
4 |
AS |
$53.25 |
$66,083 |
D/D |
(1,241) |
48,670 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2014-08-24 |
4 |
AS |
$43.55 |
$120,718 |
D/D |
(2,772) |
46,481 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
66,481 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2015-08-20 |
4 |
AS |
$42.02 |
$187,513 |
D/D |
(4,462) |
62,724 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2015-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
82,724 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-06-02 |
4 |
OE |
$10.29 |
$51,450 |
D/D |
5,000 |
88,246 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-08-22 |
4 |
AS |
$46.59 |
$185,943 |
D/D |
(3,991) |
84,255 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-08-27 |
4 |
A |
$0.00 |
$0 |
D/D |
29,000 |
113,255 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-09-22 |
4 |
AS |
$56.75 |
$127,631 |
D/D |
(2,249) |
113,255 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-09-22 |
4 |
OE |
$10.29 |
$23,142 |
D/D |
2,249 |
115,504 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-11-01 |
4 |
AS |
$51.74 |
$176,847 |
D/D |
(3,418) |
109,837 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-11-09 |
4 |
OE |
$11.09 |
$85,959 |
D/D |
7,751 |
117,588 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2016-11-09 |
4 |
AS |
$66.75 |
$517,379 |
D/D |
(7,751) |
109,837 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-01-25 |
4 |
OE |
$10.29 |
$51,450 |
D/D |
5,000 |
114,837 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-06-22 |
4 |
AS |
$64.00 |
$640,058 |
D/D |
(10,000) |
115,204 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-06-22 |
4 |
OE |
$10.29 |
$102,900 |
D/D |
10,000 |
125,204 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-07-27 |
4 |
OE |
$10.29 |
$102,900 |
D/D |
10,000 |
125,204 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-07-27 |
4 |
AS |
$54.54 |
$545,361 |
D/D |
(10,000) |
115,204 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
142,204 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-08-24 |
4 |
OE |
$10.29 |
$102,900 |
D/D |
10,000 |
152,204 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-08-24 |
4 |
AS |
$47.54 |
$475,414 |
D/D |
(10,000) |
142,204 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-08-28 |
4 |
AS |
$47.89 |
$407,199 |
D/D |
(8,502) |
133,702 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
